Ronapreve

(Note 2)Initial Approval

Casirivimab (genetical recombination) and imdevimab (genetical recombination)

Approval Information

Brand NameRonapreve

Generic NameCasirivimab (genetical recombination) and imdevimab (genetical recombination)

ApprovedJuly 2021

Type(Note 2)Initial Approval

Review Reports

English Review Report

PDF · 1.64 MB

Japanese Review Report

PDF · 1.60 MB

Want structured data, translation summaries & alerts?

PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.

Join the Waitlist

Source: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.

← Back to Drug Database